nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—SLCO1B1—breast cancer	0.278	0.629	CbGaD
SIMEPREVIR—CYP3A4—breast cancer	0.0605	0.137	CbGaD
SIMEPREVIR—ALB—breast cancer	0.0528	0.119	CbGaD
SIMEPREVIR—ABCB1—breast cancer	0.0504	0.114	CbGaD
SIMEPREVIR—CYP1A2—Anastrozole—breast cancer	0.0275	0.0737	CbGbCtD
SIMEPREVIR—CYP1A2—Toremifene—breast cancer	0.0251	0.0674	CbGbCtD
SIMEPREVIR—ABCB1—Toremifene—breast cancer	0.022	0.059	CbGbCtD
SIMEPREVIR—SLCO1B1—Irinotecan—breast cancer	0.0215	0.0578	CbGbCtD
SIMEPREVIR—CYP3A4—Exemestane—breast cancer	0.019	0.051	CbGbCtD
SIMEPREVIR—CYP3A4—Letrozole—breast cancer	0.0162	0.0433	CbGbCtD
SIMEPREVIR—ABCB1—Lapatinib—breast cancer	0.016	0.043	CbGbCtD
SIMEPREVIR—CYP3A4—Anastrozole—breast cancer	0.0144	0.0386	CbGbCtD
SIMEPREVIR—CYP3A4—Toremifene—breast cancer	0.0132	0.0353	CbGbCtD
SIMEPREVIR—CYP3A4—Fulvestrant—breast cancer	0.0122	0.0329	CbGbCtD
SIMEPREVIR—ALB—Irinotecan—breast cancer	0.0118	0.0316	CbGbCtD
SIMEPREVIR—SLCO1B1—Methotrexate—breast cancer	0.0114	0.0306	CbGbCtD
SIMEPREVIR—ALB—Fluorouracil—breast cancer	0.0113	0.0304	CbGbCtD
SIMEPREVIR—CYP3A4—Thiotepa—breast cancer	0.0109	0.0293	CbGbCtD
SIMEPREVIR—CYP3A4—Ixabepilone—breast cancer	0.00998	0.0268	CbGbCtD
SIMEPREVIR—CYP3A4—Lapatinib—breast cancer	0.0096	0.0258	CbGbCtD
SIMEPREVIR—CYP1A2—Tamoxifen—breast cancer	0.00918	0.0246	CbGbCtD
SIMEPREVIR—ABCB1—Vinorelbine—breast cancer	0.00889	0.0239	CbGbCtD
SIMEPREVIR—ABCB1—Tamoxifen—breast cancer	0.00803	0.0215	CbGbCtD
SIMEPREVIR—ABCB1—Mitoxantrone—breast cancer	0.00783	0.021	CbGbCtD
SIMEPREVIR—CYP3A4—Raloxifene—breast cancer	0.00728	0.0195	CbGbCtD
SIMEPREVIR—ABCB1—Gemcitabine—breast cancer	0.00692	0.0186	CbGbCtD
SIMEPREVIR—CYP1A2—Fluorouracil—breast cancer	0.00676	0.0182	CbGbCtD
SIMEPREVIR—ABCB1—Paclitaxel—breast cancer	0.00625	0.0168	CbGbCtD
SIMEPREVIR—ALB—Methotrexate—breast cancer	0.00624	0.0167	CbGbCtD
SIMEPREVIR—ABCB1—Irinotecan—breast cancer	0.00616	0.0165	CbGbCtD
SIMEPREVIR—ABCB1—Vinblastine—breast cancer	0.00548	0.0147	CbGbCtD
SIMEPREVIR—CYP3A4—Vinorelbine—breast cancer	0.00533	0.0143	CbGbCtD
SIMEPREVIR—CYP3A4—Tamoxifen—breast cancer	0.00481	0.0129	CbGbCtD
SIMEPREVIR—CYP3A4—Mitoxantrone—breast cancer	0.00469	0.0126	CbGbCtD
SIMEPREVIR—ABCB1—Docetaxel—breast cancer	0.00452	0.0121	CbGbCtD
SIMEPREVIR—CYP3A4—Paclitaxel—breast cancer	0.00374	0.01	CbGbCtD
SIMEPREVIR—CYP3A4—Irinotecan—breast cancer	0.00369	0.00991	CbGbCtD
SIMEPREVIR—ABCB1—Doxorubicin—breast cancer	0.00337	0.00904	CbGbCtD
SIMEPREVIR—CYP3A4—Vinblastine—breast cancer	0.00328	0.00881	CbGbCtD
SIMEPREVIR—ABCB1—Methotrexate—breast cancer	0.00326	0.00875	CbGbCtD
SIMEPREVIR—CYP3A4—Docetaxel—breast cancer	0.00271	0.00726	CbGbCtD
SIMEPREVIR—CYP3A4—Doxorubicin—breast cancer	0.00202	0.00541	CbGbCtD
SIMEPREVIR—CTSS—nipple—breast cancer	0.00174	0.0861	CbGeAlD
SIMEPREVIR—CTSS—embryo—breast cancer	0.00143	0.071	CbGeAlD
SIMEPREVIR—SLCO1B1—mammary gland—breast cancer	0.00136	0.0674	CbGeAlD
SIMEPREVIR—CTSS—skin of body—breast cancer	0.00111	0.0551	CbGeAlD
SIMEPREVIR—ALB—mammary gland—breast cancer	0.0011	0.0545	CbGeAlD
SIMEPREVIR—CTSS—endometrium—breast cancer	0.00105	0.052	CbGeAlD
SIMEPREVIR—CTSS—uterus—breast cancer	0.000967	0.0479	CbGeAlD
SIMEPREVIR—CTSS—pituitary gland—breast cancer	0.000949	0.047	CbGeAlD
SIMEPREVIR—CTSS—adipose tissue—breast cancer	0.000945	0.0468	CbGeAlD
SIMEPREVIR—CTSS—female reproductive system—breast cancer	0.000869	0.0431	CbGeAlD
SIMEPREVIR—CTSS—adrenal gland—breast cancer	0.000848	0.042	CbGeAlD
SIMEPREVIR—CTSS—bone marrow—breast cancer	0.00082	0.0407	CbGeAlD
SIMEPREVIR—CTSS—female gonad—breast cancer	0.000791	0.0392	CbGeAlD
SIMEPREVIR—CTSS—endocrine gland—breast cancer	0.000735	0.0364	CbGeAlD
SIMEPREVIR—CYP1A2—nipple—breast cancer	0.000598	0.0296	CbGeAlD
SIMEPREVIR—SLCO1B1—female reproductive system—breast cancer	0.000562	0.0279	CbGeAlD
SIMEPREVIR—CTSS—lymph node—breast cancer	0.000508	0.0252	CbGeAlD
SIMEPREVIR—SLCO1B1—endocrine gland—breast cancer	0.000476	0.0236	CbGeAlD
SIMEPREVIR—ALB—adrenal gland—breast cancer	0.000444	0.022	CbGeAlD
SIMEPREVIR—ALB—lymph node—breast cancer	0.000266	0.0132	CbGeAlD
SIMEPREVIR—CYP1A2—endocrine gland—breast cancer	0.000253	0.0125	CbGeAlD
SIMEPREVIR—ABCB1—embryo—breast cancer	0.000253	0.0125	CbGeAlD
SIMEPREVIR—CYP3A4—female reproductive system—breast cancer	0.000217	0.0107	CbGeAlD
SIMEPREVIR—ABCB1—epithelium—breast cancer	0.000206	0.0102	CbGeAlD
SIMEPREVIR—Musculoskeletal discomfort—Melphalan—breast cancer	0.000201	0.00208	CcSEcCtD
SIMEPREVIR—Dyspnoea—Tamoxifen—breast cancer	0.000201	0.00208	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	0.0002	0.00206	CcSEcCtD
SIMEPREVIR—Constipation—Vinblastine—breast cancer	0.000199	0.00205	CcSEcCtD
SIMEPREVIR—Rash—Raloxifene—breast cancer	0.000197	0.00204	CcSEcCtD
SIMEPREVIR—Rash—Idarubicin—breast cancer	0.000197	0.00204	CcSEcCtD
SIMEPREVIR—Dermatitis—Idarubicin—breast cancer	0.000197	0.00204	CcSEcCtD
SIMEPREVIR—Dermatitis—Raloxifene—breast cancer	0.000197	0.00204	CcSEcCtD
SIMEPREVIR—Dyspnoea—Melphalan—breast cancer	0.000197	0.00203	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Gemcitabine—breast cancer	0.000197	0.00203	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Goserelin—breast cancer	0.000196	0.00203	CcSEcCtD
SIMEPREVIR—Headache—Idarubicin—breast cancer	0.000196	0.00202	CcSEcCtD
SIMEPREVIR—Headache—Raloxifene—breast cancer	0.000196	0.00202	CcSEcCtD
SIMEPREVIR—Nausea—Anastrozole—breast cancer	0.000196	0.00202	CcSEcCtD
SIMEPREVIR—Nausea—Letrozole—breast cancer	0.000196	0.00202	CcSEcCtD
SIMEPREVIR—Insomnia—Goserelin—breast cancer	0.000195	0.00201	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Tamoxifen—breast cancer	0.000195	0.00201	CcSEcCtD
SIMEPREVIR—Fatigue—Tamoxifen—breast cancer	0.000195	0.00201	CcSEcCtD
SIMEPREVIR—Constipation—Tamoxifen—breast cancer	0.000193	0.00199	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Paclitaxel—breast cancer	0.000193	0.00199	CcSEcCtD
SIMEPREVIR—Myalgia—Thiotepa—breast cancer	0.000192	0.00199	CcSEcCtD
SIMEPREVIR—Dyspnoea—Goserelin—breast cancer	0.000192	0.00198	CcSEcCtD
SIMEPREVIR—Infection—Vinorelbine—breast cancer	0.000192	0.00198	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000191	0.00197	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Melphalan—breast cancer	0.000191	0.00197	CcSEcCtD
SIMEPREVIR—Fatigue—Melphalan—breast cancer	0.000191	0.00197	CcSEcCtD
SIMEPREVIR—Skin disorder—Vinorelbine—breast cancer	0.000188	0.00194	CcSEcCtD
SIMEPREVIR—Nausea—Raloxifene—breast cancer	0.000186	0.00192	CcSEcCtD
SIMEPREVIR—Nausea—Idarubicin—breast cancer	0.000186	0.00192	CcSEcCtD
SIMEPREVIR—Fatigue—Goserelin—breast cancer	0.000186	0.00192	CcSEcCtD
SIMEPREVIR—ABCB1—endometrium—breast cancer	0.000185	0.00917	CbGeAlD
SIMEPREVIR—Constipation—Goserelin—breast cancer	0.000184	0.0019	CcSEcCtD
SIMEPREVIR—Photosensitivity—Methotrexate—breast cancer	0.000184	0.0019	CcSEcCtD
SIMEPREVIR—CYP3A4—endocrine gland—breast cancer	0.000183	0.00908	CbGeAlD
SIMEPREVIR—Infection—Thiotepa—breast cancer	0.000183	0.00189	CcSEcCtD
SIMEPREVIR—Asthenia—Chlorambucil—breast cancer	0.000182	0.00188	CcSEcCtD
SIMEPREVIR—Anaemia—Mitoxantrone—breast cancer	0.00018	0.00186	CcSEcCtD
SIMEPREVIR—Anaemia—Irinotecan—breast cancer	0.00018	0.00186	CcSEcCtD
SIMEPREVIR—Pruritus—Chlorambucil—breast cancer	0.000179	0.00185	CcSEcCtD
SIMEPREVIR—Skin disorder—Thiotepa—breast cancer	0.000179	0.00185	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.000176	0.00182	CcSEcCtD
SIMEPREVIR—Anaemia—Gemcitabine—breast cancer	0.000176	0.00181	CcSEcCtD
SIMEPREVIR—Anaemia—Fluorouracil—breast cancer	0.000173	0.00178	CcSEcCtD
SIMEPREVIR—Dyspnoea—Vinorelbine—breast cancer	0.000172	0.00178	CcSEcCtD
SIMEPREVIR—Photosensitivity—Epirubicin—breast cancer	0.000172	0.00178	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Capecitabine—breast cancer	0.000171	0.00177	CcSEcCtD
SIMEPREVIR—ABCB1—uterus—breast cancer	0.000171	0.00845	CbGeAlD
SIMEPREVIR—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000168	0.00173	CcSEcCtD
SIMEPREVIR—ABCB1—pituitary gland—breast cancer	0.000167	0.0083	CbGeAlD
SIMEPREVIR—ABCB1—adipose tissue—breast cancer	0.000167	0.00826	CbGeAlD
SIMEPREVIR—Asthenia—Vinblastine—breast cancer	0.000167	0.00172	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000167	0.00172	CcSEcCtD
SIMEPREVIR—Fatigue—Vinorelbine—breast cancer	0.000166	0.00172	CcSEcCtD
SIMEPREVIR—Myalgia—Mitoxantrone—breast cancer	0.000166	0.00171	CcSEcCtD
SIMEPREVIR—Constipation—Vinorelbine—breast cancer	0.000165	0.0017	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Paclitaxel—breast cancer	0.000165	0.0017	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Docetaxel—breast cancer	0.000163	0.00168	CcSEcCtD
SIMEPREVIR—Asthenia—Tamoxifen—breast cancer	0.000162	0.00167	CcSEcCtD
SIMEPREVIR—Myalgia—Gemcitabine—breast cancer	0.000162	0.00167	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000161	0.00166	CcSEcCtD
SIMEPREVIR—Pruritus—Tamoxifen—breast cancer	0.00016	0.00165	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Thiotepa—breast cancer	0.000159	0.00164	CcSEcCtD
SIMEPREVIR—Photosensitivity—Doxorubicin—breast cancer	0.000159	0.00164	CcSEcCtD
SIMEPREVIR—Myalgia—Fluorouracil—breast cancer	0.000159	0.00164	CcSEcCtD
SIMEPREVIR—Fatigue—Thiotepa—breast cancer	0.000159	0.00164	CcSEcCtD
SIMEPREVIR—Asthenia—Melphalan—breast cancer	0.000159	0.00164	CcSEcCtD
SIMEPREVIR—Infection—Mitoxantrone—breast cancer	0.000158	0.00163	CcSEcCtD
SIMEPREVIR—Infection—Irinotecan—breast cancer	0.000158	0.00163	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Capecitabine—breast cancer	0.000158	0.00163	CcSEcCtD
SIMEPREVIR—Constipation—Thiotepa—breast cancer	0.000158	0.00163	CcSEcCtD
SIMEPREVIR—Pruritus—Melphalan—breast cancer	0.000156	0.00161	CcSEcCtD
SIMEPREVIR—Asthenia—Goserelin—breast cancer	0.000155	0.0016	CcSEcCtD
SIMEPREVIR—Skin disorder—Mitoxantrone—breast cancer	0.000155	0.0016	CcSEcCtD
SIMEPREVIR—Infection—Gemcitabine—breast cancer	0.000154	0.00159	CcSEcCtD
SIMEPREVIR—ABCB1—female reproductive system—breast cancer	0.000153	0.0076	CbGeAlD
SIMEPREVIR—Pruritus—Goserelin—breast cancer	0.000152	0.00157	CcSEcCtD
SIMEPREVIR—Infection—Fluorouracil—breast cancer	0.000151	0.00156	CcSEcCtD
SIMEPREVIR—Skin disorder—Gemcitabine—breast cancer	0.000151	0.00156	CcSEcCtD
SIMEPREVIR—Nausea—Chlorambucil—breast cancer	0.000151	0.00155	CcSEcCtD
SIMEPREVIR—ABCB1—adrenal gland—breast cancer	0.00015	0.00741	CbGeAlD
SIMEPREVIR—Anaemia—Paclitaxel—breast cancer	0.000147	0.00152	CcSEcCtD
SIMEPREVIR—Headache—Vinblastine—breast cancer	0.000146	0.0015	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000145	0.0015	CcSEcCtD
SIMEPREVIR—ABCB1—bone marrow—breast cancer	0.000145	0.00717	CbGeAlD
SIMEPREVIR—Insomnia—Irinotecan—breast cancer	0.000144	0.00149	CcSEcCtD
SIMEPREVIR—Rash—Tamoxifen—breast cancer	0.000142	0.00147	CcSEcCtD
SIMEPREVIR—Dermatitis—Tamoxifen—breast cancer	0.000142	0.00147	CcSEcCtD
SIMEPREVIR—Dyspnoea—Irinotecan—breast cancer	0.000142	0.00147	CcSEcCtD
SIMEPREVIR—Dyspnoea—Mitoxantrone—breast cancer	0.000142	0.00147	CcSEcCtD
SIMEPREVIR—Headache—Tamoxifen—breast cancer	0.000141	0.00146	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000141	0.00146	CcSEcCtD
SIMEPREVIR—Insomnia—Gemcitabine—breast cancer	0.00014	0.00145	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Docetaxel—breast cancer	0.00014	0.00144	CcSEcCtD
SIMEPREVIR—ABCB1—female gonad—breast cancer	0.00014	0.00691	CbGeAlD
SIMEPREVIR—Rash—Melphalan—breast cancer	0.000139	0.00144	CcSEcCtD
SIMEPREVIR—Dermatitis—Melphalan—breast cancer	0.000139	0.00144	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000139	0.00143	CcSEcCtD
SIMEPREVIR—Asthenia—Vinorelbine—breast cancer	0.000139	0.00143	CcSEcCtD
SIMEPREVIR—Dyspnoea—Gemcitabine—breast cancer	0.000138	0.00143	CcSEcCtD
SIMEPREVIR—Nausea—Vinblastine—breast cancer	0.000138	0.00142	CcSEcCtD
SIMEPREVIR—Insomnia—Fluorouracil—breast cancer	0.000138	0.00142	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Irinotecan—breast cancer	0.000137	0.00142	CcSEcCtD
SIMEPREVIR—Fatigue—Mitoxantrone—breast cancer	0.000137	0.00142	CcSEcCtD
SIMEPREVIR—Fatigue—Irinotecan—breast cancer	0.000137	0.00142	CcSEcCtD
SIMEPREVIR—Pruritus—Vinorelbine—breast cancer	0.000137	0.00141	CcSEcCtD
SIMEPREVIR—Constipation—Mitoxantrone—breast cancer	0.000136	0.00141	CcSEcCtD
SIMEPREVIR—Constipation—Irinotecan—breast cancer	0.000136	0.00141	CcSEcCtD
SIMEPREVIR—Dyspnoea—Fluorouracil—breast cancer	0.000136	0.0014	CcSEcCtD
SIMEPREVIR—Rash—Goserelin—breast cancer	0.000136	0.0014	CcSEcCtD
SIMEPREVIR—Dermatitis—Goserelin—breast cancer	0.000136	0.0014	CcSEcCtD
SIMEPREVIR—Myalgia—Paclitaxel—breast cancer	0.000135	0.0014	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Capecitabine—breast cancer	0.000135	0.0014	CcSEcCtD
SIMEPREVIR—Headache—Goserelin—breast cancer	0.000135	0.00139	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000135	0.00139	CcSEcCtD
SIMEPREVIR—Nausea—Tamoxifen—breast cancer	0.000134	0.00138	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000134	0.00138	CcSEcCtD
SIMEPREVIR—Fatigue—Gemcitabine—breast cancer	0.000134	0.00138	CcSEcCtD
SIMEPREVIR—Constipation—Gemcitabine—breast cancer	0.000133	0.00137	CcSEcCtD
SIMEPREVIR—Asthenia—Thiotepa—breast cancer	0.000132	0.00137	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000132	0.00136	CcSEcCtD
SIMEPREVIR—Nausea—Melphalan—breast cancer	0.000131	0.00136	CcSEcCtD
SIMEPREVIR—Pruritus—Thiotepa—breast cancer	0.00013	0.00135	CcSEcCtD
SIMEPREVIR—ABCB1—endocrine gland—breast cancer	0.00013	0.00643	CbGeAlD
SIMEPREVIR—Infection—Paclitaxel—breast cancer	0.000129	0.00133	CcSEcCtD
SIMEPREVIR—Nausea—Goserelin—breast cancer	0.000128	0.00132	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Methotrexate—breast cancer	0.000127	0.00131	CcSEcCtD
SIMEPREVIR—Skin disorder—Paclitaxel—breast cancer	0.000126	0.0013	CcSEcCtD
SIMEPREVIR—Anaemia—Docetaxel—breast cancer	0.000125	0.00129	CcSEcCtD
SIMEPREVIR—Rash—Vinorelbine—breast cancer	0.000122	0.00126	CcSEcCtD
SIMEPREVIR—Dermatitis—Vinorelbine—breast cancer	0.000122	0.00126	CcSEcCtD
SIMEPREVIR—Headache—Vinorelbine—breast cancer	0.000121	0.00125	CcSEcCtD
SIMEPREVIR—Anaemia—Capecitabine—breast cancer	0.000121	0.00125	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Epirubicin—breast cancer	0.000119	0.00123	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000118	0.00122	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Methotrexate—breast cancer	0.000118	0.00121	CcSEcCtD
SIMEPREVIR—Insomnia—Paclitaxel—breast cancer	0.000117	0.00121	CcSEcCtD
SIMEPREVIR—Rash—Thiotepa—breast cancer	0.000116	0.0012	CcSEcCtD
SIMEPREVIR—Dermatitis—Thiotepa—breast cancer	0.000116	0.0012	CcSEcCtD
SIMEPREVIR—Dyspnoea—Paclitaxel—breast cancer	0.000116	0.0012	CcSEcCtD
SIMEPREVIR—Headache—Thiotepa—breast cancer	0.000115	0.00119	CcSEcCtD
SIMEPREVIR—Myalgia—Docetaxel—breast cancer	0.000115	0.00119	CcSEcCtD
SIMEPREVIR—Nausea—Vinorelbine—breast cancer	0.000115	0.00118	CcSEcCtD
SIMEPREVIR—Asthenia—Mitoxantrone—breast cancer	0.000114	0.00118	CcSEcCtD
SIMEPREVIR—Asthenia—Irinotecan—breast cancer	0.000114	0.00118	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000114	0.00118	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000112	0.00116	CcSEcCtD
SIMEPREVIR—Fatigue—Paclitaxel—breast cancer	0.000112	0.00116	CcSEcCtD
SIMEPREVIR—Asthenia—Gemcitabine—breast cancer	0.000111	0.00115	CcSEcCtD
SIMEPREVIR—Myalgia—Capecitabine—breast cancer	0.000111	0.00115	CcSEcCtD
SIMEPREVIR—Constipation—Paclitaxel—breast cancer	0.000111	0.00115	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.00011	0.00114	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Doxorubicin—breast cancer	0.00011	0.00114	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Epirubicin—breast cancer	0.00011	0.00114	CcSEcCtD
SIMEPREVIR—Pruritus—Gemcitabine—breast cancer	0.00011	0.00113	CcSEcCtD
SIMEPREVIR—Nausea—Thiotepa—breast cancer	0.00011	0.00113	CcSEcCtD
SIMEPREVIR—Infection—Docetaxel—breast cancer	0.000109	0.00113	CcSEcCtD
SIMEPREVIR—Pruritus—Fluorouracil—breast cancer	0.000108	0.00111	CcSEcCtD
SIMEPREVIR—Skin disorder—Docetaxel—breast cancer	0.000107	0.0011	CcSEcCtD
SIMEPREVIR—Infection—Capecitabine—breast cancer	0.000106	0.00109	CcSEcCtD
SIMEPREVIR—Skin disorder—Capecitabine—breast cancer	0.000104	0.00107	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Doxorubicin—breast cancer	0.000102	0.00105	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Methotrexate—breast cancer	0.000101	0.00104	CcSEcCtD
SIMEPREVIR—Rash—Irinotecan—breast cancer	0.0001	0.00104	CcSEcCtD
SIMEPREVIR—Rash—Mitoxantrone—breast cancer	0.0001	0.00104	CcSEcCtD
SIMEPREVIR—Dermatitis—Mitoxantrone—breast cancer	0.0001	0.00104	CcSEcCtD
SIMEPREVIR—Dermatitis—Irinotecan—breast cancer	0.0001	0.00104	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Docetaxel—breast cancer	0.0001	0.00104	CcSEcCtD
SIMEPREVIR—Headache—Irinotecan—breast cancer	9.97e-05	0.00103	CcSEcCtD
SIMEPREVIR—Headache—Mitoxantrone—breast cancer	9.97e-05	0.00103	CcSEcCtD
SIMEPREVIR—Insomnia—Docetaxel—breast cancer	9.95e-05	0.00103	CcSEcCtD
SIMEPREVIR—Dyspnoea—Docetaxel—breast cancer	9.81e-05	0.00101	CcSEcCtD
SIMEPREVIR—Rash—Gemcitabine—breast cancer	9.78e-05	0.00101	CcSEcCtD
SIMEPREVIR—Dermatitis—Gemcitabine—breast cancer	9.77e-05	0.00101	CcSEcCtD
SIMEPREVIR—Headache—Gemcitabine—breast cancer	9.72e-05	0.001	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Capecitabine—breast cancer	9.71e-05	0.001	CcSEcCtD
SIMEPREVIR—Insomnia—Capecitabine—breast cancer	9.64e-05	0.000995	CcSEcCtD
SIMEPREVIR—Rash—Fluorouracil—breast cancer	9.61e-05	0.000993	CcSEcCtD
SIMEPREVIR—Dermatitis—Fluorouracil—breast cancer	9.61e-05	0.000992	CcSEcCtD
SIMEPREVIR—Headache—Fluorouracil—breast cancer	9.55e-05	0.000986	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Docetaxel—breast cancer	9.5e-05	0.000981	CcSEcCtD
SIMEPREVIR—Dyspnoea—Capecitabine—breast cancer	9.5e-05	0.000981	CcSEcCtD
SIMEPREVIR—Fatigue—Docetaxel—breast cancer	9.49e-05	0.00098	CcSEcCtD
SIMEPREVIR—Nausea—Mitoxantrone—breast cancer	9.46e-05	0.000976	CcSEcCtD
SIMEPREVIR—Nausea—Irinotecan—breast cancer	9.46e-05	0.000976	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Epirubicin—breast cancer	9.42e-05	0.000972	CcSEcCtD
SIMEPREVIR—Constipation—Docetaxel—breast cancer	9.41e-05	0.000972	CcSEcCtD
SIMEPREVIR—Asthenia—Paclitaxel—breast cancer	9.32e-05	0.000962	CcSEcCtD
SIMEPREVIR—Nausea—Gemcitabine—breast cancer	9.21e-05	0.000951	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Capecitabine—breast cancer	9.2e-05	0.00095	CcSEcCtD
SIMEPREVIR—Fatigue—Capecitabine—breast cancer	9.19e-05	0.000949	CcSEcCtD
SIMEPREVIR—Pruritus—Paclitaxel—breast cancer	9.19e-05	0.000948	CcSEcCtD
SIMEPREVIR—Constipation—Capecitabine—breast cancer	9.11e-05	0.000941	CcSEcCtD
SIMEPREVIR—Nausea—Fluorouracil—breast cancer	9.06e-05	0.000935	CcSEcCtD
SIMEPREVIR—Anaemia—Methotrexate—breast cancer	8.98e-05	0.000927	CcSEcCtD
SIMEPREVIR—ABCB1—lymph node—breast cancer	8.97e-05	0.00444	CbGeAlD
SIMEPREVIR—Mediastinal disorder—Doxorubicin—breast cancer	8.71e-05	0.0009	CcSEcCtD
SIMEPREVIR—Anaemia—Epirubicin—breast cancer	8.41e-05	0.000868	CcSEcCtD
SIMEPREVIR—Myalgia—Methotrexate—breast cancer	8.27e-05	0.000854	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.22e-05	0.000848	CcSEcCtD
SIMEPREVIR—Rash—Paclitaxel—breast cancer	8.19e-05	0.000845	CcSEcCtD
SIMEPREVIR—Dermatitis—Paclitaxel—breast cancer	8.18e-05	0.000844	CcSEcCtD
SIMEPREVIR—Headache—Paclitaxel—breast cancer	8.13e-05	0.00084	CcSEcCtD
SIMEPREVIR—Asthenia—Docetaxel—breast cancer	7.9e-05	0.000815	CcSEcCtD
SIMEPREVIR—Infection—Methotrexate—breast cancer	7.88e-05	0.000814	CcSEcCtD
SIMEPREVIR—Pruritus—Docetaxel—breast cancer	7.79e-05	0.000804	CcSEcCtD
SIMEPREVIR—Anaemia—Doxorubicin—breast cancer	7.78e-05	0.000803	CcSEcCtD
SIMEPREVIR—Myalgia—Epirubicin—breast cancer	7.74e-05	0.0008	CcSEcCtD
SIMEPREVIR—Nausea—Paclitaxel—breast cancer	7.71e-05	0.000796	CcSEcCtD
SIMEPREVIR—Skin disorder—Methotrexate—breast cancer	7.71e-05	0.000796	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.69e-05	0.000794	CcSEcCtD
SIMEPREVIR—Asthenia—Capecitabine—breast cancer	7.65e-05	0.000789	CcSEcCtD
SIMEPREVIR—Pruritus—Capecitabine—breast cancer	7.54e-05	0.000778	CcSEcCtD
SIMEPREVIR—Infection—Epirubicin—breast cancer	7.38e-05	0.000761	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Methotrexate—breast cancer	7.23e-05	0.000746	CcSEcCtD
SIMEPREVIR—Skin disorder—Epirubicin—breast cancer	7.21e-05	0.000744	CcSEcCtD
SIMEPREVIR—Insomnia—Methotrexate—breast cancer	7.17e-05	0.000741	CcSEcCtD
SIMEPREVIR—Myalgia—Doxorubicin—breast cancer	7.17e-05	0.00074	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.12e-05	0.000735	CcSEcCtD
SIMEPREVIR—Dyspnoea—Methotrexate—breast cancer	7.07e-05	0.00073	CcSEcCtD
SIMEPREVIR—Rash—Docetaxel—breast cancer	6.94e-05	0.000716	CcSEcCtD
SIMEPREVIR—Dermatitis—Docetaxel—breast cancer	6.93e-05	0.000716	CcSEcCtD
SIMEPREVIR—Headache—Docetaxel—breast cancer	6.89e-05	0.000712	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Methotrexate—breast cancer	6.85e-05	0.000707	CcSEcCtD
SIMEPREVIR—Fatigue—Methotrexate—breast cancer	6.84e-05	0.000706	CcSEcCtD
SIMEPREVIR—Infection—Doxorubicin—breast cancer	6.82e-05	0.000705	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Epirubicin—breast cancer	6.76e-05	0.000698	CcSEcCtD
SIMEPREVIR—Rash—Capecitabine—breast cancer	6.72e-05	0.000694	CcSEcCtD
SIMEPREVIR—Insomnia—Epirubicin—breast cancer	6.71e-05	0.000693	CcSEcCtD
SIMEPREVIR—Dermatitis—Capecitabine—breast cancer	6.71e-05	0.000693	CcSEcCtD
SIMEPREVIR—Headache—Capecitabine—breast cancer	6.68e-05	0.000689	CcSEcCtD
SIMEPREVIR—Skin disorder—Doxorubicin—breast cancer	6.67e-05	0.000689	CcSEcCtD
SIMEPREVIR—Dyspnoea—Epirubicin—breast cancer	6.62e-05	0.000683	CcSEcCtD
SIMEPREVIR—Nausea—Docetaxel—breast cancer	6.54e-05	0.000675	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Epirubicin—breast cancer	6.41e-05	0.000662	CcSEcCtD
SIMEPREVIR—Fatigue—Epirubicin—breast cancer	6.4e-05	0.000661	CcSEcCtD
SIMEPREVIR—Constipation—Epirubicin—breast cancer	6.35e-05	0.000655	CcSEcCtD
SIMEPREVIR—Nausea—Capecitabine—breast cancer	6.33e-05	0.000653	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.26e-05	0.000646	CcSEcCtD
SIMEPREVIR—Insomnia—Doxorubicin—breast cancer	6.21e-05	0.000641	CcSEcCtD
SIMEPREVIR—Dyspnoea—Doxorubicin—breast cancer	6.12e-05	0.000632	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Doxorubicin—breast cancer	5.93e-05	0.000612	CcSEcCtD
SIMEPREVIR—Fatigue—Doxorubicin—breast cancer	5.92e-05	0.000611	CcSEcCtD
SIMEPREVIR—Constipation—Doxorubicin—breast cancer	5.87e-05	0.000606	CcSEcCtD
SIMEPREVIR—Asthenia—Methotrexate—breast cancer	5.69e-05	0.000588	CcSEcCtD
SIMEPREVIR—Pruritus—Methotrexate—breast cancer	5.61e-05	0.000579	CcSEcCtD
SIMEPREVIR—Asthenia—Epirubicin—breast cancer	5.33e-05	0.00055	CcSEcCtD
SIMEPREVIR—Pruritus—Epirubicin—breast cancer	5.25e-05	0.000542	CcSEcCtD
SIMEPREVIR—Rash—Methotrexate—breast cancer	5e-05	0.000516	CcSEcCtD
SIMEPREVIR—Dermatitis—Methotrexate—breast cancer	5e-05	0.000516	CcSEcCtD
SIMEPREVIR—Headache—Methotrexate—breast cancer	4.97e-05	0.000513	CcSEcCtD
SIMEPREVIR—Asthenia—Doxorubicin—breast cancer	4.93e-05	0.000509	CcSEcCtD
SIMEPREVIR—Pruritus—Doxorubicin—breast cancer	4.86e-05	0.000502	CcSEcCtD
SIMEPREVIR—Nausea—Methotrexate—breast cancer	4.71e-05	0.000486	CcSEcCtD
SIMEPREVIR—Rash—Epirubicin—breast cancer	4.68e-05	0.000483	CcSEcCtD
SIMEPREVIR—Dermatitis—Epirubicin—breast cancer	4.68e-05	0.000483	CcSEcCtD
SIMEPREVIR—Headache—Epirubicin—breast cancer	4.65e-05	0.00048	CcSEcCtD
SIMEPREVIR—Nausea—Epirubicin—breast cancer	4.41e-05	0.000455	CcSEcCtD
SIMEPREVIR—Rash—Doxorubicin—breast cancer	4.33e-05	0.000447	CcSEcCtD
SIMEPREVIR—Dermatitis—Doxorubicin—breast cancer	4.33e-05	0.000447	CcSEcCtD
SIMEPREVIR—Headache—Doxorubicin—breast cancer	4.3e-05	0.000444	CcSEcCtD
SIMEPREVIR—Nausea—Doxorubicin—breast cancer	4.08e-05	0.000421	CcSEcCtD
SIMEPREVIR—CYP1A2—Metabolism—GPX4—breast cancer	5.3e-06	7.69e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SULT1A1—breast cancer	5.3e-06	7.69e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.29e-06	7.69e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—MTR—breast cancer	5.22e-06	7.58e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CPT1A—breast cancer	5.22e-06	7.58e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ABCG2—breast cancer	5.22e-06	7.58e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP2D6—breast cancer	5.21e-06	7.57e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.21e-06	7.56e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.21e-06	7.56e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—RAF1—breast cancer	5.19e-06	7.54e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—IDH1—breast cancer	5.17e-06	7.51e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTA1—breast cancer	5.17e-06	7.51e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CAV1—breast cancer	5.15e-06	7.48e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HPGDS—breast cancer	5.12e-06	7.44e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NAT2—breast cancer	5.11e-06	7.43e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NCOA2—breast cancer	5.11e-06	7.43e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HBA1—breast cancer	5.09e-06	7.39e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CB—breast cancer	5.07e-06	7.36e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—FHL2—breast cancer	4.99e-06	7.25e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ADSL—breast cancer	4.99e-06	7.25e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NME1—breast cancer	4.99e-06	7.25e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—UMPS—breast cancer	4.99e-06	7.25e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PHGDH—breast cancer	4.99e-06	7.25e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTT1—breast cancer	4.97e-06	7.21e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ACHE—breast cancer	4.97e-06	7.21e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—FASN—breast cancer	4.96e-06	7.2e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—BCHE—breast cancer	4.94e-06	7.17e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.92e-06	7.15e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—BRIP1—breast cancer	4.9e-06	7.11e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HPSE—breast cancer	4.9e-06	7.11e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—LDHB—breast cancer	4.9e-06	7.11e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	4.9e-06	7.11e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC5A5—breast cancer	4.88e-06	7.09e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	4.82e-06	7e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NQO1—breast cancer	4.71e-06	6.84e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC2A1—breast cancer	4.71e-06	6.84e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP17A1—breast cancer	4.7e-06	6.83e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CG—breast cancer	4.69e-06	6.82e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTGS1—breast cancer	4.65e-06	6.76e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ENO1—breast cancer	4.65e-06	6.76e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IL2—breast cancer	4.65e-06	6.76e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HMMR—breast cancer	4.64e-06	6.74e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTA3—breast cancer	4.64e-06	6.74e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCC1—breast cancer	4.64e-06	6.74e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.62e-06	6.71e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.61e-06	6.7e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP3A4—breast cancer	4.59e-06	6.67e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.57e-06	6.64e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP2D6—breast cancer	4.57e-06	6.63e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP1B1—breast cancer	4.52e-06	6.56e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.5e-06	6.53e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	4.49e-06	6.53e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MED12—breast cancer	4.48e-06	6.51e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—DPYD—breast cancer	4.48e-06	6.51e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOA2—breast cancer	4.48e-06	6.51e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—HSP90AA1—breast cancer	4.43e-06	6.43e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ALDOA—breast cancer	4.41e-06	6.41e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	4.35e-06	6.32e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—FASN—breast cancer	4.35e-06	6.31e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—BCHE—breast cancer	4.33e-06	6.28e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NCOA1—breast cancer	4.31e-06	6.26e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOA3—breast cancer	4.29e-06	6.22e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC5A5—breast cancer	4.27e-06	6.21e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC2A2—breast cancer	4.26e-06	6.18e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—STK11—breast cancer	4.25e-06	6.17e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP19A1—breast cancer	4.25e-06	6.17e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTA4—breast cancer	4.25e-06	6.17e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CA9—breast cancer	4.25e-06	6.17e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.21e-06	6.12e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ABCG2—breast cancer	4.17e-06	6.05e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CPT1A—breast cancer	4.17e-06	6.05e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MTR—breast cancer	4.17e-06	6.05e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTA2—breast cancer	4.14e-06	6.01e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GPX2—breast cancer	4.14e-06	6.01e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC2A1—breast cancer	4.13e-06	6e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NQO1—breast cancer	4.13e-06	6e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CD—breast cancer	4.13e-06	5.99e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HPGDS—breast cancer	4.09e-06	5.94e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SULT1A1—breast cancer	4.09e-06	5.94e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GPX4—breast cancer	4.09e-06	5.94e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ALB—breast cancer	4.07e-06	5.92e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HBA1—breast cancer	4.06e-06	5.9e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SRC—breast cancer	4.06e-06	5.9e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP3A4—breast cancer	4.03e-06	5.85e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—IDH1—breast cancer	3.99e-06	5.8e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTA1—breast cancer	3.99e-06	5.8e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.99e-06	5.79e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTT1—breast cancer	3.97e-06	5.76e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ACHE—breast cancer	3.97e-06	5.76e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP1B1—breast cancer	3.96e-06	5.75e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—VEGFA—breast cancer	3.96e-06	5.74e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—COMT—breast cancer	3.95e-06	5.73e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NAT2—breast cancer	3.95e-06	5.73e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.94e-06	5.72e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTP1—breast cancer	3.93e-06	5.71e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NOS3—breast cancer	3.9e-06	5.66e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HSP90AA1—breast cancer	3.88e-06	5.64e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—HMOX1—breast cancer	3.88e-06	5.63e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ITPR1—breast cancer	3.87e-06	5.62e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOA1—breast cancer	3.78e-06	5.48e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP17A1—breast cancer	3.75e-06	5.45e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—MAPK3—breast cancer	3.74e-06	5.43e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—STK11—breast cancer	3.72e-06	5.4e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP19A1—breast cancer	3.72e-06	5.4e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ABCB1—breast cancer	3.72e-06	5.4e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ENO1—breast cancer	3.72e-06	5.4e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTGS1—breast cancer	3.72e-06	5.4e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.7e-06	5.38e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.65e-06	5.31e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—TYMS—breast cancer	3.65e-06	5.31e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP2D6—breast cancer	3.64e-06	5.29e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TGFB1—breast cancer	3.63e-06	5.27e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PLA2G4A—breast cancer	3.61e-06	5.24e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NCOR1—breast cancer	3.61e-06	5.24e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTM1—breast cancer	3.61e-06	5.24e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CB—breast cancer	3.6e-06	5.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOA2—breast cancer	3.58e-06	5.19e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTGS2—breast cancer	3.56e-06	5.17e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—FASN—breast cancer	3.47e-06	5.04e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—DPYD—breast cancer	3.46e-06	5.03e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MED12—breast cancer	3.46e-06	5.03e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—COMT—breast cancer	3.46e-06	5.02e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GPX1—breast cancer	3.46e-06	5.02e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—BCHE—breast cancer	3.45e-06	5.02e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTP1—breast cancer	3.44e-06	5e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP1A1—breast cancer	3.42e-06	4.97e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC5A5—breast cancer	3.41e-06	4.96e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALDOA—breast cancer	3.41e-06	4.95e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HMOX1—breast cancer	3.4e-06	4.93e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ERCC2—breast cancer	3.4e-06	4.93e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ITPR1—breast cancer	3.39e-06	4.92e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—KRAS—breast cancer	3.36e-06	4.88e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOA3—breast cancer	3.31e-06	4.8e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NQO1—breast cancer	3.3e-06	4.79e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC2A1—breast cancer	3.3e-06	4.79e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC2A2—breast cancer	3.28e-06	4.77e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.23e-06	4.69e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MTR—breast cancer	3.22e-06	4.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CPT1A—breast cancer	3.22e-06	4.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCG2—breast cancer	3.22e-06	4.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP3A4—breast cancer	3.21e-06	4.67e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—TYMS—breast cancer	3.2e-06	4.65e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.2e-06	4.64e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—MTHFR—breast cancer	3.19e-06	4.64e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PLA2G4A—breast cancer	3.16e-06	4.6e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOR1—breast cancer	3.16e-06	4.6e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTM1—breast cancer	3.16e-06	4.6e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP1B1—breast cancer	3.16e-06	4.59e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HPGDS—breast cancer	3.16e-06	4.58e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HBA1—breast cancer	3.14e-06	4.55e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTEN—breast cancer	3.11e-06	4.51e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.1e-06	4.5e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CA—breast cancer	3.09e-06	4.49e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTT1—breast cancer	3.06e-06	4.44e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ACHE—breast cancer	3.06e-06	4.44e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GPX1—breast cancer	3.03e-06	4.4e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOA1—breast cancer	3.01e-06	4.38e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP1A1—breast cancer	3e-06	4.36e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—breast cancer	2.99e-06	4.34e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ERCC2—breast cancer	2.98e-06	4.32e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—STK11—breast cancer	2.97e-06	4.31e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP19A1—breast cancer	2.97e-06	4.31e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CAV1—breast cancer	2.94e-06	4.28e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP17A1—breast cancer	2.9e-06	4.21e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ENO1—breast cancer	2.87e-06	4.17e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTGS1—breast cancer	2.87e-06	4.17e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—HRAS—breast cancer	2.86e-06	4.15e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.81e-06	4.08e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP2D6—breast cancer	2.81e-06	4.08e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—MTHFR—breast cancer	2.8e-06	4.06e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.79e-06	4.05e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—COMT—breast cancer	2.76e-06	4.01e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOA2—breast cancer	2.76e-06	4.01e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTP1—breast cancer	2.75e-06	3.99e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HMOX1—breast cancer	2.71e-06	3.94e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ITPR1—breast cancer	2.7e-06	3.93e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CG—breast cancer	2.68e-06	3.89e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—FASN—breast cancer	2.68e-06	3.89e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—BCHE—breast cancer	2.67e-06	3.87e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC5A5—breast cancer	2.63e-06	3.82e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ABCB1—breast cancer	2.6e-06	3.78e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CAV1—breast cancer	2.58e-06	3.75e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—TYMS—breast cancer	2.56e-06	3.71e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC2A1—breast cancer	2.54e-06	3.69e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NQO1—breast cancer	2.54e-06	3.69e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTM1—breast cancer	2.53e-06	3.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOR1—breast cancer	2.53e-06	3.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.53e-06	3.67e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—AKT1—breast cancer	2.52e-06	3.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP1B1—breast cancer	2.44e-06	3.54e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GPX1—breast cancer	2.42e-06	3.51e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP1A1—breast cancer	2.39e-06	3.48e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.39e-06	3.47e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ERCC2—breast cancer	2.37e-06	3.45e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CD—breast cancer	2.36e-06	3.42e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CG—breast cancer	2.35e-06	3.41e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOA1—breast cancer	2.33e-06	3.38e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—STK11—breast cancer	2.29e-06	3.33e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP19A1—breast cancer	2.29e-06	3.33e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MTHFR—breast cancer	2.23e-06	3.24e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NOS3—breast cancer	2.23e-06	3.23e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CA—breast cancer	2.19e-06	3.18e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—COMT—breast cancer	2.13e-06	3.1e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTP1—breast cancer	2.12e-06	3.08e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HMOX1—breast cancer	2.09e-06	3.04e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ITPR1—breast cancer	2.09e-06	3.03e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CD—breast cancer	2.07e-06	3e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CAV1—breast cancer	2.06e-06	2.99e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CB—breast cancer	2.05e-06	2.98e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ALB—breast cancer	2.04e-06	2.96e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTGS2—breast cancer	2.04e-06	2.96e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCB1—breast cancer	2.01e-06	2.92e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TYMS—breast cancer	1.97e-06	2.86e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.97e-06	2.86e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NOS3—breast cancer	1.95e-06	2.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.95e-06	2.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTM1—breast cancer	1.95e-06	2.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOR1—breast cancer	1.95e-06	2.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CG—breast cancer	1.88e-06	2.72e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GPX1—breast cancer	1.87e-06	2.71e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP1A1—breast cancer	1.85e-06	2.68e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ERCC2—breast cancer	1.83e-06	2.66e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CB—breast cancer	1.8e-06	2.61e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—AKT1—breast cancer	1.79e-06	2.6e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTGS2—breast cancer	1.78e-06	2.59e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTEN—breast cancer	1.78e-06	2.58e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MTHFR—breast cancer	1.72e-06	2.5e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CD—breast cancer	1.65e-06	2.39e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ALB—breast cancer	1.63e-06	2.36e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CAV1—breast cancer	1.59e-06	2.31e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NOS3—breast cancer	1.56e-06	2.26e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTEN—breast cancer	1.56e-06	2.26e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CG—breast cancer	1.45e-06	2.1e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CB—breast cancer	1.44e-06	2.09e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTGS2—breast cancer	1.42e-06	2.07e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CD—breast cancer	1.27e-06	1.85e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALB—breast cancer	1.26e-06	1.82e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CA—breast cancer	1.25e-06	1.82e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTEN—breast cancer	1.24e-06	1.8e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NOS3—breast cancer	1.2e-06	1.75e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CB—breast cancer	1.11e-06	1.61e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTGS2—breast cancer	1.1e-06	1.6e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CA—breast cancer	1.1e-06	1.59e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—AKT1—breast cancer	1.02e-06	1.49e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTEN—breast cancer	9.58e-07	1.39e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—AKT1—breast cancer	8.97e-07	1.3e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CA—breast cancer	8.76e-07	1.27e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—AKT1—breast cancer	7.16e-07	1.04e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CA—breast cancer	6.76e-07	9.82e-06	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—AKT1—breast cancer	5.52e-07	8.02e-06	CbGpPWpGaD
